Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Kasper, S; Quiner, S; Barnas, C; Fabisch, H; Haushofer, M; Sackel, C; König, P; Lingg, A; Platz, T; Rittmannsberger, H; Stuppäck, C; Willeit, M; Zapotoczky, HG.
Zotepine in the treatment of acute hospitalized schizophrenic episodes.
INT CLIN PSYCHOPHARMACOL. 2001; 16(3): 163-168.
Doi: 10.1097%2F00004850-200105000-00005
Web of Science
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fabisch Johann
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The atypical antipsychotic zotepine was studied in an open, multicentre uncontrolled, post-marketing surveillance study in 108 schizophrenic patients hospitalized in 12 trial centres in Austria. Within the dosage range of 50-450 mg (mean at the end of the study, 207 +/- 125 mg/day), a significant reduction of positive as well as negative symptoms was noted. There was no increase in extrapyramidal side-effects during the study and a significant decrease in akathisia scores. The medication was well tolerated during the 42-day observation period. Zotepine improved both positive and negative symptoms and was not accompanied by extrapyramidal side-effects, justifying its classification as an atypical antipsychotic. Int clin Psychopharmacol 16:163-168 (C) 2001 Lippincott Williams & Wilkins.
- Find related publications in this database (Keywords)
- antipsychotics
- atypical antipsychotics
- post-marketing surveillance study
- schizophrenia
- zotepine